Azasugar inhibitors as pharmacological chaperones for Krabbe disease12. Issue 5 (20th May 2015) - Hill, Chris H.
Abstract Modified azasugar molecules have been synthesized and characterized as excellent pharmacological chaperone candidates to treat the neurodegenerative disorder Krabbe disease.